|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 200.00 IDR | +1.01% |
|
+8.70% | -10.71% |
| Market Cap | 337B 18.93M 16.39M 15.32M 14M 26.39M 1.81B 26.8M 180M 70.5M 903M 71.1M 69.54M 3.01B | P/E 2024 |
82x | P/E 2025 | -13.1x |
|---|---|---|---|---|---|
| Enterprise Value | 461B 25.9M 22.42M 20.96M 19.15M 36.09M 2.47B 36.65M 246M 96.42M 1.24B 97.24M 95.12M 4.12B | EV / Sales 2024 |
1.35x | EV / Sales 2025 | 1.38x |
| Free-Float |
20% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +1.01% | ||
| 1 week | +8.70% | ||
| Current month | +6.95% | ||
| 1 month | +11.11% | ||
| 3 months | +0.50% | ||
| 6 months | -23.66% | ||
| Current year | -10.71% |
| 1 week | 187 |  | 208 |
| 1 month | 174 | | 220 |
| Current year | 167 | | 340 |
| 1 year | 167 | | 340 |
| 3 years | 164 | | 340 |
| 5 years | 164 | | 340 |
| 10 years | 164 | | 340 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kartono Gunawa
CEO | Chief Executive Officer | 58 | 21/06/2023 |
Handri Sutanto
AUD | Comptroller/Controller/Auditor | 46 | 28/06/2023 |
| Corporate Officer/Principal | 53 | 01/01/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 85 | 18/05/1978 | |
Titianus Winata
BRD | Director/Board Member | 90 | 01/01/2016 |
Susanto Lam
BRD | Director/Board Member | 58 | 21/06/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.01% | +8.70% | +3.09% | - | 18.93M | |
| +3.90% | +9.86% | +96.91% | +136.30% | 1,098B | |
| +0.99% | +2.91% | +51.05% | +52.06% | 631B | |
| +0.78% | +1.17% | +25.21% | +63.74% | 438B | |
| -0.43% | +4.80% | +51.42% | +39.79% | 368B | |
| +0.04% | +1.85% | +34.81% | +39.99% | 298B | |
| -0.80% | +4.26% | +9.78% | +7.42% | 251B | |
| +1.52% | +10.12% | +44.75% | +59.20% | 226B | |
| +0.69% | +1.27% | -5.23% | -50.94% | 209B | |
| -0.11% | +1.46% | +11.43% | +66.32% | 165B | |
| Average | +1.15% | +3.21% | +32.32% | +45.99% | 368.44B | |
| Weighted average by Cap. | +1.80% | +4.82% | +52.19% | +68.54% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 412B 23.16M 20.05M 18.74M 17.13M 32.27M 2.21B 32.78M 220M 86.22M 1.1B 86.95M 85.05M 3.68B | 364B 20.43M 17.69M 16.53M 15.11M 28.47M 1.95B 28.92M 194M 76.07M 975M 76.72M 75.04M 3.25B |
| Net income | 5.01B 282K 244K 228K 208K 393K 26.88M 399K 2.67M 1.05M 13.45M 1.06M 1.04M 44.78M | -28.78B -1.62M -1.4M -1.31M -1.2M -2.25M -154M -2.29M -15.35M -6.02M -77.18M -6.07M -5.94M -257M |
| Net Debt | 147B 8.27M 7.16M 6.69M 6.12M 11.52M 789M 11.7M 78.47M 30.79M 395M 31.05M 30.37M 1.31B | 124B 6.96M 6.03M 5.63M 5.15M 9.7M 664M 9.86M 66.07M 25.92M 332M 26.14M 25.57M 1.11B |
Employees
1,031
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/08/26 | IDR 200.00 | +1.01% | 892,800 |
| 07/08/26 | IDR 198.00 | +1.54% | 78,400 |
| 06/08/26 | IDR 195.00 | +2.63% | 440,400 |
| 05/08/26 | IDR 190.00 | -1.04% | 36,800 |
| 04/08/26 | IDR 192.00 | +4.35% | 88,800 |
- Stock Market
- Stocks
- IKPM Stock
Select your edition
All financial news and data tailored to specific country editions
